IMAGE GALLERY:
Welcome on Board, Hemolens Diagnostics!
23/04/2025
BACK
We are delighted to welcome Hemolens Diagnostics as a new member of the Avicenna Alliance!
Based in Poland, Hemolens is an innovative MedTech startup at the forefront of cardiovascular diagnostics and in silico technologies.
Hemolens was recently ranked among the top 10 Polish entities for patent filings in 2024 by the European Patent Office—a testament to their commitment to innovation.
Their flagship product, Cardiolens FFR-CT Pro, exemplifies Hemolens' advanced capabilities: a non-invasive diagnostic tool that reconstructs coronary arteries from CT scans, using AI, BME, and CFD to assess the risk of ischemia. It is part of the Cardiolens Platform – an integrated suite developed to support cardiologists and radiologists in accurate, early detection and management of coronary artery disease.
The technology enables earlier diagnosis and risk assessment, helping to optimize patient pathways and improve outcomes.
We’re thrilled to have Hemolens’ expertise onboard and look forward to collaborating with them in shaping the future of predictive medicine.
Learn more about Hemolens Diagnostics.
